Medco European Ventures Continue To Build; Partnership With Celesio To Focus First On Germany
This article was originally published in The Pink Sheet Daily
Executive Summary
Medco's efforts to expand its clinical services to budget-strapped health care payers in Europe will begin to contribute "meaningfully" to its bottom line by 2015, according to CEO David Snow.
You may also be interested in...
European Health Care Agencies Add Medco Clinical Services To Price Controls
European health care agencies are increasingly interested in new clinical service programs for drugs to create greater cost savings in light of growing inflation and budget deficits, according to Medco executives
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.